Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health

McGill University

$100,000.00

Eicosanoids and Dual-Specificity Phosphatases (DUSPs): critical regulators of the inflammatory response.

EF 2010-11

Résumé
Our entire research program is based on finding new and more efficacious drug therapies for treating patients with various forms of inflammatory arthritis, including rheumatoid arthritis (RA). Thus, it is essential that we develop a firm understanding regarding the underlying pathological mechanisms of the disease(s) since only then can molecular targets be identified that are potentially amenable to therapeutic intervention. We have undertaken this work with colleagues in academia and industry. The current proposal examines the effects of PGs on dual specificity phosphatases (DUSPs), which are normally programmed to control cellular responses to inflammatory mediators, growth factors, and cancer causing agents by moderating MAP and stress kinase activity. Our preliminary studies indicated that DUSP levels/activity were perturbed in RA synovial membranes. We will examine the mechanism by which DUSP expression is compromised and identify critical intracellular targets affected by the loss of proper DUSP function, as they may be linked to the disease process. In addition, the loss of PG synthesis, due to NSAID use, also results in profound DUSP dysregulation in RA-synovial joint tissues, thus clearly linking the PG synthetic machinery with DUSP regulation. The evidence suggests that DUSPs provide a valid therapeutic target for RA and indeed a number of companies are working on small molecules that regulate DUSP expression and activity in cancer.
Programme
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
219715
Name
Di Battista Giovanni (John) A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Eicosanoids and Dual-Specificity Phosphatases (DUSPs): critical regulators of the inflammatory response.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Keyworddelim
Arthritis; Bioactive Lipids; Cell Signaling; Dual Specificity Kinases; Eicosanoids; G Protein-Coupled Receptors; Gene Regulation; Inflammation; Map Kinases; Translational Regulation
Abstract
Our entire research program is based on finding new and more efficacious drug therapies for treating patients with various forms of inflammatory arthritis, including rheumatoid arthritis (RA). Thus, it is essential that we develop a firm understanding regarding the underlying pathological mechanisms of the disease(s) since only then can molecular targets be identified that are potentially amenable to therapeutic intervention. We have undertaken this work with colleagues in academia and industry. The current proposal examines the effects of PGs on dual specificity phosphatases (DUSPs), which are normally programmed to control cellular responses to inflammatory mediators, growth factors, and cancer causing agents by moderating MAP and stress kinase activity. Our preliminary studies indicated that DUSP levels/activity were perturbed in RA synovial membranes. We will examine the mechanism by which DUSP expression is compromised and identify critical intracellular targets affected by the loss of proper DUSP function, as they may be linked to the disease process. In addition, the loss of PG synthesis, due to NSAID use, also results in profound DUSP dysregulation in RA-synovial joint tissues, thus clearly linking the PG synthetic machinery with DUSP regulation. The evidence suggests that DUSPs provide a valid therapeutic target for RA and indeed a number of companies are working on small molecules that regulate DUSP expression and activity in cancer.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Battista, Giovanni (John) A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~